These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 11558226)

  • 1. [Phagotherapy in terms of bacteriophage genetics: hopes, perspectives, safety, limitations].
    Krylov VN
    Genetika; 2001 Jul; 37(7):869-87. PubMed ID: 11558226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage therapy: a reappraisal of bacteriophages as antibiotics.
    Inal JM
    Arch Immunol Ther Exp (Warsz); 2003; 51(4):237-44. PubMed ID: 12956433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophages: an appraisal of their role in the treatment of bacterial infections.
    Hanlon GW
    Int J Antimicrob Agents; 2007 Aug; 30(2):118-28. PubMed ID: 17566713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage therapy: past history and future prospects.
    Carlton RM
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):267-74. PubMed ID: 10604231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophage therapy: an alternative to conventional antibiotics.
    Mathur MD; Vidhani S; Mehndiratta PL
    J Assoc Physicians India; 2003 Jun; 51():593-6. PubMed ID: 15266928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phagotherapy of postoperative suppurative-inflammatory complications in patients with neoplasms].
    Kochetkova VA; Mamontov AS; Moskovtseva RL; Erastova EI; Trofimov EI; Popov MI; Dzhubalieva SK
    Sov Med; 1989; (6):23-6. PubMed ID: 2799488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriophage therapy in children: facts and prospects.
    Fortuna W; Miedzybrodzki R; Weber-Dabrowska B; Górski A
    Med Sci Monit; 2008 Aug; 14(8):RA126-32. PubMed ID: 18668009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New perspectives of the phage therapy].
    Eyer L; Pantůcek R; Růzicková V; Doskar J
    Klin Mikrobiol Infekc Lek; 2007 Dec; 13(6):231-5. PubMed ID: 18320502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reinventing phage therapy: are the parts greater than the sum?
    Fischetti VA; Nelson D; Schuch R
    Nat Biotechnol; 2006 Dec; 24(12):1508-11. PubMed ID: 17160051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophage therapy: exploiting smaller fleas.
    Deresinski S
    Clin Infect Dis; 2009 Apr; 48(8):1096-101. PubMed ID: 19275495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prospect for bacteriophage therapy in Western medicine.
    Merril CR; Scholl D; Adhya SL
    Nat Rev Drug Discov; 2003 Jun; 2(6):489-97. PubMed ID: 12776223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides.
    Parisien A; Allain B; Zhang J; Mandeville R; Lan CQ
    J Appl Microbiol; 2008 Jan; 104(1):1-13. PubMed ID: 18171378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophages as potential new therapeutics to replace or supplement antibiotics.
    Kutateladze M; Adamia R
    Trends Biotechnol; 2010 Dec; 28(12):591-5. PubMed ID: 20810181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacteriophages as antibacterial agents].
    Shasha SM; Sharon N; Inbar M
    Harefuah; 2004 Feb; 143(2):121-5, 166. PubMed ID: 15143702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting phage therapy: new applications for old resources.
    Nobrega FL; Costa AR; Kluskens LD; Azeredo J
    Trends Microbiol; 2015 Apr; 23(4):185-91. PubMed ID: 25708933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics.
    Ahmad SI
    Med Hypotheses; 2002 Apr; 58(4):327-31. PubMed ID: 12027527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.
    Ryan EM; Gorman SP; Donnelly RF; Gilmore BF
    J Pharm Pharmacol; 2011 Oct; 63(10):1253-64. PubMed ID: 21899540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factors of bacteriophage resistance to cellular nucleases in phagotherapy of microbial infections].
    Nikol'skaia II; Debov SS
    Vestn Akad Med Nauk SSSR; 1984; (8):41-8. PubMed ID: 6093404
    [No Abstract]   [Full Text] [Related]  

  • 20. Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.
    Burrowes B; Harper DR; Anderson J; McConville M; Enright MC
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):775-85. PubMed ID: 21905786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.